<DOC>
	<DOCNO>NCT02507011</DOCNO>
	<brief_summary>The investigator conduct , randomize , phase 2 , placebo-controlled , double-blinded , crossover trial carvedilol 26 PAH patient World Health Organization functional class II III symptom RV ejection fraction ( EF ) &lt; 45 % 6 month .</brief_summary>
	<brief_title>Beta-blockers Pulmonary Arterial Hypertension</brief_title>
	<detailed_description>Adult PAH patient stable dose approve PAH medication undergo follow baseline assessment : cardiac magnetic resonance imaging ( MRI ) , right heart catheterization ( RHC ) , echocardiogram , 6-minute walk test ( 6-MWT ) , plasma NT-ProBNP ( biomarkers RV function ) serum catecholamine ( measure sympathetic activation ) , quality life . Patients randomized carvedilol ( 3.125 mg bid escalate 9.375 mg bid , tolerate , 3 month ) placebo 1:1 fashion . After 6 month , test repeat patient crossed alternate treatment . Testing repeated end study ( month 13 ) .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<criteria>Age &gt; 18 year WHO category 1 pulmonary arterial hypertension ( Nice 2013 ) WHO functional class IIIII RVEF cardiac MRI &lt; 45 % Stable PAHspecific therapy define change PAHspecific treatment functional class past 3 month . Patient either mono combination PAHspecific therapy Subjects exclude participation study follow condition exist : Significant persistent bradycardia ( rest heart rate &lt; 60 bpm ) without permanent pacemaker Second third degree AV block without permanent pacemaker Significant sinus tachycardia ( rest heart rate &gt; 110 bpm ) Use antiarrhythmic drug Hypotension define systolic blood pressure &lt; 100 mmHg time enrollment Significant illness past 30 day require hospitalization Acute decompensated right heart failure within past 30 day Known allergy intolerance carvedilol Î² blocker Cardiac index &lt; 2 l/min/m2 right atrial pressure &gt; 15 mm Hg right heart catheterization within last 3 month Asthma Positive pregnancy test patient child bearingpotential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>